Cassava Sciences Inc(SAVA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SAVA Cassava Sciences Inc

盘前交易 12-19 05:25:09 EST

2.41

-0.14

-5.49%

盘前2.40

-0.01-0.41%

05:21 EST

最高2.64	最低2.39	成交量294.66万
今开2.52	昨收2.55	日振幅9.80%
总市值1.16亿	流通市值1.04亿	总股本4,811万
成交额744.10万	换手率6.81%	流通股本4,327万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"SAVA","market":"US","secType":"STK","nameCN":"Cassava Sciences Inc","latestPrice":2.41,"timestamp":1734555600000,"preClose":2.55,"halted":0,"volume":2946621,"hourTrading":{"tag":"盘前","latestPrice":2.4,"preClose":2.41,"latestTime":"05:21 EST","volume":6049,"amount":14518.739631600001,"timestamp":1734603718593},"delay":0,"floatShares":43274073,"shares":48110475,"eps":-1.37344,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.14,"latestTime":"12-19 05:25:09 EST","open":2.52,"high":2.64,"low":2.39,"amount":7440985.325108401,"amplitude":0.098039,"askPrice":2.63,"askSize":100,"bidPrice":2.19,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.37344,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734618600000},"adr":0,"adjPreClose":2.41,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":2.4,"preClose":2.41,"latestTime":"05:21 EST","volume":6049,"amount":14518.739631600001,"timestamp":1734603718593},"postHourTrading":{"tag":"盘后","latestPrice":2.44,"preClose":2.41,"latestTime":"19:59 EST","volume":106550,"amount":257051.0823,"timestamp":1734569990928},"volumeRatio":1.0599019844122923,"impliedVol":1.3104,"impliedVolPercentile":0.5697},"requestUrl":"/m/hq/s/SAVA/wiki","defaultTab":"wiki","newsList":[{"id":"2492154903","title":"木薯科学盘中异动 股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492154903","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492154903?lang=zh_cn&edition=full","pubTime":"2024-12-19 04:36","pubTimestamp":1734554212,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日04时36分，木薯科学股票出现异动，股价快速下挫5.10%。截至发稿，该股报2.42美元/股，成交量227.192万股，换手率4.72%，振幅8.24%。木薯科学股票所在的生物技术行业中，整体跌幅为2.57%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219043653ab829f20&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219043653ab829f20&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4547","BK4588","SAVA","BK4585","BK4007"],"gpt_icon":0},{"id":"2492021979","title":"中关村(000931.SZ)：氨酚羟考酮片上市许可申请获得受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2492021979","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492021979?lang=zh_cn&edition=full","pubTime":"2024-12-18 16:27","pubTimestamp":1734510448,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中关村 发布公告，公司下属公司北京华素制药股份有限公司于近日收到国家药品监督管理局签发的《受理通知书》，氨酚羟考酮片上市许可申请获得受理。据悉，氨酚羟考酮片适用于严重程度足以需要使用阿片类镇痛剂且缺乏其他替代治疗的中、重度疼痛的治疗。本品原研未在中国境内上市，目前境内已有3家仿制药获批上市，北京华素是第4家提交本品上市许可申请的境内企业。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1226482.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","SAVA","BK4007","000931","BK0075","BK0178","BK0239","BK4585","BK4547","BK4588"],"gpt_icon":0},{"id":"2490542774","title":"木薯科学盘中异动 快速下跌5.28%报3.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490542774","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490542774?lang=zh_cn&edition=full","pubTime":"2024-12-09 23:38","pubTimestamp":1733758702,"startTime":"0","endTime":"0","summary":"北京时间2024年12月09日23时38分，木薯科学股票出现波动，股价急速下挫5.28%。截至发稿，该股报3.05美元/股，成交量151.481万股，换手率3.15%，振幅4.97%。木薯科学股票所在的生物技术行业中，整体涨幅为1.11%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209233822ab6a2d9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209233822ab6a2d9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4547","BK4007","SAVA","BK4585"],"gpt_icon":0},{"id":"2489237831","title":"木薯科学盘中异动 早盘快速拉升5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489237831","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489237831?lang=zh_cn&edition=full","pubTime":"2024-12-06 23:31","pubTimestamp":1733499066,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日23时31分，木薯科学股票出现异动，股价急速上涨5.19%。截至发稿，该股报3.22美元/股，成交量135.779万股，换手率2.82%，振幅5.71%。木薯科学股票所在的生物技术行业中，整体涨幅为0.72%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120623310698e5e454&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120623310698e5e454&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4547","BK4585","SAVA","BK4588"],"gpt_icon":1},{"id":"1143328374","title":"异动解读 | 阿尔茨海默药物研发取得进展，Cassava Sciences盘中大涨7.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=1143328374","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143328374?lang=zh_cn&edition=full","pubTime":"2024-12-06 00:12","pubTimestamp":1733415175,"startTime":"0","endTime":"0","summary":"Cassava Sciences公司今日盘中大涨7.46%，引发了市场广泛关注。\n\n该公司目前正在进行两项针对阿尔茨海默病患者的3期临床试验，测试其候选药物simufilam的疗效。这一进展为simufilam成为阿尔茨海默病有效治疗药物带来了期望，提振了投资者对公司前景的信心。\n\nCassava Sciences是一家专注于阿尔茨海默病诊疗的生物技术公司。除了simufilam外，该公司还开发了SavaDx诊断产品, 可通过血液样本检测阿尔茨海默病。随着候选产品研发进入关键阶段,公司盈利前景趋于乐观,因此股价出现大涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 阿尔茨海默药物研发取得进展，Cassava Sciences盘中大涨7.46%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["SAVA"],"gpt_icon":0},{"id":"2489469211","title":"木薯科学盘中异动 股价大涨5.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489469211","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489469211?lang=zh_cn&edition=full","pubTime":"2024-12-05 23:57","pubTimestamp":1733414255,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日23时57分，木薯科学股票出现波动，股价快速拉升5.93%。截至发稿，该股报3.13美元/股，成交量359.372万股，换手率7.47%，振幅10.17%。木薯科学股票所在的生物技术行业中，整体涨幅为0.40%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205235735ab602749&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205235735ab602749&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","SAVA","BK4547","BK4588","BK4007"],"gpt_icon":1},{"id":"2489003115","title":"木薯科学盘中异动 快速下跌5.37%报3.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489003115","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489003115?lang=zh_cn&edition=full","pubTime":"2024-12-04 23:51","pubTimestamp":1733327497,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日23时51分，木薯科学股票出现异动，股价急速下挫5.37%。截至发稿，该股报3.17美元/股，成交量252.696万股，换手率5.25%，振幅5.07%。木薯科学股票所在的生物技术行业中，整体跌幅为0.03%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204235137a26c8643&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204235137a26c8643&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4547","BK4585","BK4588","SAVA"],"gpt_icon":1},{"id":"2488941837","title":"木薯科学盘中异动 早盘快速跳水5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488941837","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488941837?lang=zh_cn&edition=full","pubTime":"2024-12-03 22:38","pubTimestamp":1733236715,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日22时38分，木薯科学股票出现异动，股价大幅下跌5.08%。木薯科学股票所在的生物技术行业中，整体跌幅为0.17%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。公司的研究诊断产品候选是SavaDx，它是一种从少量血液样本中检测阿尔茨海默病存在的新方法，可能在临床症状明显出现前几年。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203223835abf2fc37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203223835abf2fc37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4007","BK4547","SAVA","BK4585"],"gpt_icon":1},{"id":"2488677330","title":"木薯科学盘中异动 早盘快速下挫6.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488677330","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488677330?lang=zh_cn&edition=full","pubTime":"2024-12-02 22:31","pubTimestamp":1733149914,"startTime":"0","endTime":"0","summary":"北京时间2024年12月02日22时31分，木薯科学股票出现异动，股价快速下跌6.51%。截至发稿，该股报3.59美元/股，成交量52.3733万股，换手率1.09%，振幅2.19%。木薯科学股票所在的生物技术行业中，整体跌幅为0.03%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120222315498e4eb26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120222315498e4eb26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4547","SAVA","BK4007","BK4588"],"gpt_icon":1},{"id":"2487633775","title":"木薯科学盘中异动 股价大跌5.02%报3.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2487633775","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487633775?lang=zh_cn&edition=full","pubTime":"2024-11-29 22:39","pubTimestamp":1732891198,"startTime":"0","endTime":"0","summary":"北京时间2024年11月29日22时39分，木薯科学股票出现异动，股价大幅跳水5.02%。截至发稿，该股报3.78美元/股，成交量112.607万股，换手率2.34%，振幅4.77%。木薯科学股票所在的生物技术行业中，整体跌幅为0.30%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129223958971aa6f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129223958971aa6f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4585","BK4547","SAVA","BK4588"],"gpt_icon":1},{"id":"2486882011","title":"木薯科学盘中异动 早盘大幅拉升5.08%报4.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486882011","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486882011?lang=zh_cn&edition=full","pubTime":"2024-11-27 22:42","pubTimestamp":1732718563,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日22时42分，木薯科学股票出现波动，股价快速上涨5.08%。截至发稿，该股报4.02美元/股，成交量237.155万股，换手率4.93%，振幅8.37%。木薯科学股票所在的生物技术行业中，整体涨幅为0.11%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112722424398e44ef3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112722424398e44ef3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4585","SAVA","BK4547","BK4007"],"gpt_icon":1},{"id":"1139085272","title":"异动解读 | 阿尔茨海默症药物试验宣布停止,Cassava Sciences Inc盘中暴跌5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=1139085272","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139085272?lang=zh_cn&edition=full","pubTime":"2024-11-26 22:34","pubTimestamp":1732631694,"startTime":"0","endTime":"0","summary":"Cassava Sciences Inc今日盘中股价暴跌5.47%,引发市场关注。\n消息显示,这家总部位于德克萨斯州奥斯汀的生物技术公司宣布将停止长期争夺监管部门批准的阿尔茨海默氏症实验药物的高级临床试验。之前该公司一直致力于推进这款阿尔茨海默症新药的审批进程,但如今宣布终止实验显然令投资者失望,加大了市场对公司前景的担忧,导致股价大幅下跌。\n阿尔茨海默症疾病一直是医药行业渴望突破的难题,Cassava Sciences宣布放弃此前的努力无疑令市场信心受挫。公司未来能否开发出新的潜在药物将成为投资者关注的焦点。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | 阿尔茨海默症药物试验宣布停止,Cassava Sciences Inc盘中暴跌5.47%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["SAVA"],"gpt_icon":0},{"id":"2486000289","title":"木薯科学盘中异动 股价大跌6.87%报4.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486000289","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486000289?lang=zh_cn&edition=full","pubTime":"2024-11-26 22:34","pubTimestamp":1732631652,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日22时34分，木薯科学股票出现异动，股价急速跳水6.87%。截至发稿，该股报4.00美元/股，成交量363.928万股，换手率7.56%，振幅7.68%。木薯科学股票所在的生物技术行业中，整体跌幅为0.23%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126223412abe0bdad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126223412abe0bdad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4547","BK4007","SAVA","BK4585"],"gpt_icon":1},{"id":"2486830048","title":"新闻摘要-纽约时报》商业新闻 - 11 月 26 日","url":"https://stock-news.laohu8.com/highlight/detail?id=2486830048","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486830048?lang=zh_cn&edition=full","pubTime":"2024-11-26 13:55","pubTimestamp":1732600543,"startTime":"0","endTime":"0","summary":"    路透社11月26日 - 以下是《纽约时报》商业版的热门新闻。路透社没有核实这些新闻，也不保证其准确性。- 梅西百货  称，一名员工在过去几年中 \"故意 \"虚报 ，并隐瞒了高达1.54亿美元的配送费用，迫使该零售商推迟发布备受期待的财报。- 总部位于得克萨斯州奥斯汀的生物技术公司Cassava Sciences   宣布将停止 ，结束长期争夺监管部门批准的阿尔茨海默氏症实验药物的高级临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2361044865.SGD","BK4581","LU1066053197.SGD","LU0211327993.USD","LU0640476718.USD","BK4533","LU0175139822.USD","KSS","LU0149725797.USD","LU2430703095.HKD","BK4532","LU0314104364.USD","LU2125154935.USD","LU2430703178.SGD","RIVN","LU1066051225.USD","LU2264538146.SGD","LU2592432038.USD","LU2125154778.USD","IE0034235188.USD","LU0417517546.SGD","LU2360032135.SGD","LU1116320737.USD","BK4504","LU1064131342.USD","LU1430594728.SGD","BK4534","LU1267930490.SGD","BK4547","WMT","LU2430703251.USD","LU0310799852.SGD","LU1069347547.HKD","BK4155","LU2461242641.AUD","BK4007","LU1988902786.USD","LU1280957306.USD","BK4597","LU2505996681.GBP","M","LU1035773651.USD","LU0256863811.USD","LU1585245621.USD","BK4111","NYT","SAVA","LU1066051811.HKD","BK4099","LU2505996509.AUD"],"gpt_icon":1},{"id":"1187872929","title":"Cassava Sciences暴跌84%，阿尔茨海默症治疗试验未达预期效果","url":"https://stock-news.laohu8.com/highlight/detail?id=1187872929","media":"智通财经网","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187872929?lang=zh_cn&edition=full","pubTime":"2024-11-25 23:29","pubTimestamp":1732548584,"startTime":"0","endTime":"0","summary":"将停止Refocus-ALZ试验。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/content/detail/1215697.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"Cassava Sciences周一暴跌，阿尔茨海默症治疗试验未达预期效果","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["SAVA"],"gpt_icon":0},{"id":"2486103377","title":"Simufilam 3期阿尔茨海默氏症试验未达到终点 Cassava Sciences暴跌超84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486103377","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486103377?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:55","pubTimestamp":1732546555,"startTime":"0","endTime":"0","summary":"周一，cassava sciences(SAVA.US)股价暴跌，截至发稿，该股跌超84%，报4.06美元。该公司表示，其simufilam治疗轻度至中度阿尔茨海默症的3期ReThink-ALZ研究的初步结果没有达到预先设定的共同主要终点、次要终点和探索性生物标志物终点。该公司总裁兼首席执行官里克.巴里表示：“对于患有这种疾病的患者及其家属以及一直在寻找新治疗方案的医生来说，结果令人失望。鉴于今天公布结果，我们做出了停止Refocus-ALZ试验的艰难决定。该研究将提供完整的52周数据集以及76周数据的很大一部分。我们打算将来报告对这两项研究的详细分析。我们还将终止开放标签扩展研究。”","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125230552abde0ba9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125230552abde0ba9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4547","BK4585","BK4588","SAVA"],"gpt_icon":0},{"id":"2486033312","title":"美股异动 | Simufilam 3期阿尔茨海默氏症试验未达到终点 Cassava Sciences(SAVA.US)暴跌超84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486033312","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486033312?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:35","pubTimestamp":1732545358,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周一，Cassava Sciences股价暴跌，截至发稿，该股跌超84%，报4.06美元。该公司表示，其simufilam治疗轻度至中度阿尔茨海默症的3期ReThink-ALZ研究的初步结果没有达到预先设定的共同主要终点、次要终点和探索性生物标志物终点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1215697.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","SAVA","BK4547","BK4585","BK4007"],"gpt_icon":0},{"id":"2486162038","title":"木薯科学股价重挫85.89% 市值跌1.75亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486162038","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486162038?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:32","pubTimestamp":1732545150,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时32分，木薯科学股票出现波动，股价快速跳水85.89%。截至发稿，该股报3.74美元/股，成交量2653.23万股，换手率55.15%，振幅1.89%。木薯科学股票所在的生物技术行业中，整体涨幅为0.97%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112522323098e44643&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112522323098e44643&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","SAVA","BK4547","BK4585","BK4007"],"gpt_icon":1},{"id":"2485252261","title":"木薯科学盘中异动 早盘股价大跌5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485252261","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485252261?lang=zh_cn&edition=full","pubTime":"2024-11-22 22:34","pubTimestamp":1732286095,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日22时34分，木薯科学股票出现异动，股价急速下挫5.22%。截至发稿，该股报30.50美元/股，成交量30.8394万股，换手率0.64%，振幅2.89%。木薯科学股票所在的生物技术行业中，整体涨幅为0.30%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122223456abd79390&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122223456abd79390&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4547","BK4007","SAVA","BK4585","VRPX"],"gpt_icon":0},{"id":"2485413222","title":"木薯科学盘中异动 股价大涨5.01%报27.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485413222","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485413222?lang=zh_cn&edition=full","pubTime":"2024-11-21 23:13","pubTimestamp":1732202012,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日23时13分，木薯科学股票出现异动，股价快速上涨5.01%。截至发稿，该股报27.36美元/股，成交量18.7698万股，换手率0.39%，振幅4.68%。木薯科学股票所在的生物技术行业中，整体跌幅为0.46%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112123133298e43f24&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112123133298e43f24&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SAVA","BK4007","BK4588","BK4547","BK4585"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cassavasciences.com","stockEarnings":[{"period":"1week","weight":-0.1544},{"period":"1month","weight":-0.9138},{"period":"3month","weight":-0.9206},{"period":"6month","weight":-0.8796},{"period":"1year","weight":-0.9143},{"period":"ytd","weight":-0.8929}],"compareEarnings":[{"period":"1week","weight":-0.0349},{"period":"1month","weight":-0.0032},{"period":"3month","weight":0.0268},{"period":"6month","weight":0.0767},{"period":"1year","weight":0.2347},{"period":"ytd","weight":0.2335}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cassava Sciences, Inc.是一家致力于开发新药的生物制药企业。公司主要候选药物称为羟考酮 (oxycodone) 缓释胶囊 。羟考酮是功效强大的止痛药，其独特的配方有助于减少非计划用量的潜在威胁。羟考酮和其他三种非滥用止疼药是按照与国王制药股份有限公司（King Pharmaceuticals, Inc.）的合作以及许可证协议（Pfizer Agreements）开发研制的。国王制药股份有限公司是辉瑞制药股份有限公司（Pfizer, Inc.）的子公司。公司于1998年5月在特拉华州注册成立。","yearOnYearQuotes":[{"month":1,"riseRate":0.541667,"avgChangeRate":0.155421},{"month":2,"riseRate":0.416667,"avgChangeRate":0.028198},{"month":3,"riseRate":0.458333,"avgChangeRate":0.024377},{"month":4,"riseRate":0.583333,"avgChangeRate":0.060573},{"month":5,"riseRate":0.416667,"avgChangeRate":0.028089},{"month":6,"riseRate":0.458333,"avgChangeRate":-0.016342},{"month":7,"riseRate":0.458333,"avgChangeRate":0.000768},{"month":8,"riseRate":0.48,"avgChangeRate":0.013502},{"month":9,"riseRate":0.6,"avgChangeRate":0.108222},{"month":10,"riseRate":0.4,"avgChangeRate":-0.045759},{"month":11,"riseRate":0.6,"avgChangeRate":-0.00953},{"month":12,"riseRate":0.36,"avgChangeRate":0.032946}],"exchange":"NASDAQ","name":"Cassava Sciences Inc","nameEN":"Cassava Sciences Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cassava Sciences Inc(SAVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cassava Sciences Inc(SAVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cassava Sciences Inc,SAVA,Cassava Sciences Inc股票,Cassava Sciences Inc股票老虎,Cassava Sciences Inc股票老虎国际,Cassava Sciences Inc行情,Cassava Sciences Inc股票行情,Cassava Sciences Inc股价,Cassava Sciences Inc股市,Cassava Sciences Inc股票价格,Cassava Sciences Inc股票交易,Cassava Sciences Inc股票购买,Cassava Sciences Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cassava Sciences Inc(SAVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cassava Sciences Inc(SAVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}